A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection
Clicks: 390
ID: 113374
1996
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
5.7
/100
19 views
19 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
A monthly application of mupirocin ointment in staphylococcal carriers reduces the incidence of nasal colonization, which in turn lowers the risk of skin infection.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (24 words).
Try re-searching for a better abstract.
| Reference Key |
r1996archivesa
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Raz R;Miron D;Colodner R;Staler Z;Samara Z;Keness Y;; |
| Journal | archives of internal medicine |
| Year | 1996 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Administration
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
adult
female
male
adolescent
middle aged
Child
Recurrence
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
mupirocin / administration & dosage
mupirocin / therapeutic use*
pmid:8638999
r raz
d miron
y keness
topical
carrier state*
nose / microbiology*
staphylococcal skin infections / prevention & control*
staphylococcus aureus / isolation & purification*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.